Insight Molecular Diagnostics (IMDX) Change in Receivables (2020 - 2025)
Historic Change in Receivables for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to -$254000.0.
- Insight Molecular Diagnostics' Change in Receivables fell 30483.87% to -$254000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $49000.0, marking a year-over-year increase of 11929.13%. This contributed to the annual value of $1.1 million for FY2024, which is 113577.98% up from last year.
- According to the latest figures from Q3 2025, Insight Molecular Diagnostics' Change in Receivables is -$254000.0, which was down 30483.87% from -$3.0 million recorded in Q2 2025.
- In the past 5 years, Insight Molecular Diagnostics' Change in Receivables ranged from a high of $1.9 million in Q1 2025 and a low of -$3.0 million during Q2 2025
- In the last 5 years, Insight Molecular Diagnostics' Change in Receivables had a median value of $22000.0 in 2022 and averaged $77315.8.
- As far as peak fluctuations go, Insight Molecular Diagnostics' Change in Receivables surged by 658571.43% in 2024, and later plummeted by 388421.05% in 2025.
- Quarter analysis of 5 years shows Insight Molecular Diagnostics' Change in Receivables stood at $405000.0 in 2021, then tumbled by 94.57% to $22000.0 in 2022, then dropped by 4.55% to $21000.0 in 2023, then surged by 6585.71% to $1.4 million in 2024, then tumbled by 118.09% to -$254000.0 in 2025.
- Its last three reported values are -$254000.0 in Q3 2025, -$3.0 million for Q2 2025, and $1.9 million during Q1 2025.